Median Technologies said it will be providing imaging support for a Phase II clinical trial on non-small cell lung cancer sponsored by Oxford Oncology. The study will involve clinical sites in China, Japan, South Korea and Taiwan. Median will oversee the central reviews of medical images collected in the research.

Full Story:

Related Summaries